Publication | Closed Access

Engineering CAR-NK cells targeting CD33 with concomitant extracellular secretion of anti-CD16 antibody revealed superior antitumor effects toward myeloid leukemia

Hematological MalignancyCancer ImmunosurveillanceMalignant Blood DisorderImmunologyCar-nk CellsAutoimmunityAnti-cd16 AntibodyMyeloid LeukemiaImmunotherapyMedicineCell BiologyTumor Microenvironment